Candesartan CAS 139481-59-7 Purity > 99.0% (HPLC) Hoobkas

Lus piav qhia luv luv:

Lub npe tshuaj: Candesartan

CAS: 139481-59-7 Nr

Purity:> 99.0% (HPLC)

Cov tsos mob: Dawb hmoov

Ib qho Selective Angiotensin II Receptor Antagonist

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chemical Properties:

Tshuaj npe Candesartan
Synonyms CV-11974;2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-Benzimidazole-7-Carboxylic Acid;3-[[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl]-2-ethoxy-3H-Benzimidazole-4-Carboxylic Acid;Candesartan M1;Candesartan Cilexetil EP Impurity G
CAS Nr 139481-59-7
CAT Number Qauv: RF-PI1889
Tshuag xwm txheej Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula C24H20N6O3
Molecular Luj 440.45 Nws
Hom Ruifu Tshuaj

Specifications:

Yam khoom Specifications
Qhov tshwm sim Dawb hmoov
Identification-HPLC Lub Sijhawm Retention Similar to Standard
ID-IR Zoo ib yam li Standard
Purity / Analysis Method > 99.0% (HPLC)
Melting Point 183.0 ~ 185.0 ℃
Poob rau ziab <0.50%
Moisture (KF) <0.50%
Residue ntawm Ignition <0.50%
Hnyav Hlau <20 ppm
Tus kheej impurity <1.00% (HPLC)
Tag nrho cov impurities <1.00% (HPLC)
Refractive Index n20/D 1.745~1.747
Test Standard Enterprise Standard
Kev siv API;Rau Kev Kho Mob Ntshav Siab

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo

Qhov zoo:

1

FAQ:

Daim ntawv thov:

Candesartan (CAS: 139481-59-7) yog angiotensin II receptor antagonist nrog IC50 ntawm 0.26 nM.Lub Hom Phiaj: Angiotensin II Receptor candesartan yog qhia rau kev kho mob ntshav siab.Candesartan Cilexetil tau pom zoo thawj zaug hauv GB thaum Lub Plaub Hlis 29, 1997, tom qab ntawv pom zoo los ntawm US Food and Drug Administration (FDA) thaum Lub Rau Hli 4, 1998, thiab tau pom zoo los ntawm Pharmaceuticals thiab Medical Devices Agency of Japan (PMDA) thaum Lub Peb Hlis 12, 1999. Nws tau tsim los ntawm AstraZeneca, tom qab ntawd ua lag luam raws li Atacand los ntawm AstraZeneca hauv GB thiab Asmeskas, thiab ua lag luam raws li Blopress los ntawm Takeda hauv JP.Candesartan Cilexetil yog angiotensin II receptor blocker (ARB), nws thaiv cov vasoconstrictor thiab aldosterone-secreting teebmeem ntawm angiotensin II los ntawm kev xaiv thaiv kev khi ntawm angiotensin II rau AT1 receptor nyob rau hauv ntau cov ntaub so ntswg, xws li vascular du nqaij thiab cov qog adrenal.Atacand tau qhia rau kev kho mob ntshav siab hauv cov neeg laus thiab cov menyuam yaus hnub nyoog 1 txog <17 xyoo, lub plawv tsis ua haujlwm (NYHA chav kawm II-IV) thiab siv los txo cov hlab plawv tuag thiab mob plawv tsis ua haujlwm hauv tsev kho mob.

Sau koj cov lus ntawm no thiab xa tuaj rau peb